Clinical Trial Details

Short Title
Official Title
Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

Participants in this research study have been diagnosed with a type of soft tissue sarcoma called liposarcoma that has spread to other parts of the body or is not able to be removed with surgery. This research study is being performed at about 8 clinics across the United States and approximately 38 people will participate. The purpose of the study is to see if the study drug pazopanib is safe and effective with subjects with liposarcoma. 

Start Date
October 22, 2012
End Date
October 22, 2022
Gender Preference
Age Group
18 - 99 years
Principal Investigator
Mohammed Milhem, MD
Contact Info

Mohammed Milhem, 319-356-2324

Adipose tissue ; Cancer ; Connective Tissue ; IRB#201205509 ; Liposarcoma ; Metastatic Liposarcoma ; Milhem ; Neoplasms ; Pazopanib ; Phase 2 ; Phase II ; Sarcoma ; Soft Tissue ; Soft tissue sarcoma ; Surgically Unresectable Liposarcoma ;

We'd welcome your feedback!

Please help us improve your experience on our website by completing a brief survey

Yes, I'll give feedback No, Thanks